An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
J Neural Transm (Vienna)
; 126(1): 5-18, 2019 Jan.
Article
in En
| MEDLINE
| ID: mdl-30191366
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cytochrome P-450 CYP2D6
/
Drug-Related Side Effects and Adverse Reactions
/
Precision Medicine
/
Vitamin K Epoxide Reductases
/
Cytochrome P-450 CYP2C9
/
Cytochrome P-450 CYP2C19
/
Pharmacogenomic Variants
Type of study:
Prognostic_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Country/Region as subject:
Oceania
Language:
En
Journal:
J Neural Transm (Vienna)
Year:
2019
Type:
Article
Affiliation country:
Australia